Chakraborty Lab

Saint Louis University

PHARMACOLOGY

Saint Louis · United States

NIH-funded
Rate this labNo reviews yet — be the first.

Research focus

NIH R01 · 2025

Determining hepatocyte-specific mechanisms by which Ube4A regulates NAFLD/NASH

Project summary Obesity is a major risk factor for NAFLD/NASH. In obesity, energy accumulation causes metabolic dysfunction and endoplasmic reticulum (ER) and oxidative stress, leading to tissue inflammation and injury, which are hallmarks of NASH. The DNA damage response and unfolded protein response are vital to maintain the integrity of cellular genome and proteome. The ER maintains proteostasis via ER-associated protein degradation and unfolded protein response. Metabolic dysfunction alters ER-associated protein degradation and unfolded protein response, leading to ER stress, caspase activation and cell death. Moreover, increased oxidative stress enhances DNA damage-induced cell death.…

From the public funding record at NIH RePORTER. Describes the funded project, not the reviews below.

Reviews

← All labs at Saint Louis University